Document is current
Any future updates will be listed below
-
Authors
Grau-Pujol, Berta http://orcid.org/0000-0002-7320-0965
Camprubí-Ferrer, Daniel
Marti-Soler, Helena
Fernández-Pardos, Marc
Carreras-Abad, Clara
Andrés, Maria Velasco-de
Ferrer, Elisabet
Muelas-Fernandez, Magdalena
Jullien, Sophie
Barilaro, Giuseppe
Ajanovic, Sara
Vera, Isabel
Moreno, Laura
Gonzalez-Redondo, Eva
Cortes-Serra, Núria
Roldán, Montserrat
Arcos, Ana Artes-de
Mur, Isabel
Domingo, Pere
Garcia, Felipe
Guinovart, Caterina
Muñoz, Jose
-
Funding
Funding for this research was provided by:
ISGlobal
Laboratoris Rubió
- License Information
-
More Information
Article History
Received: 23 March 2021
Accepted: 25 October 2021
First Online: 15 November 2021
Declarations
:
: This trial was approved by the Drug Research Ethics Committee of the Hospital Clinic of Barcelona (CEIm), Barcelona, Spain, and the Spanish Agency of Medicines and Medical Products (AEMPS).The study was performed according to the Declaration of Helsinki (version of Fortaleza, Brazil, October 2013), current ICH-GCP guidelines, and all applicable national and local regulatory requirements (Spanish Royal Decree 1090/2015).Informed consent was signed by all participants before their inclusion in the study. Participation in this study was voluntary, and under no circumstances the clinical management of the participants was affected by the decision to participate or not in the study. The participant was free to withdraw at any time of the study.
: Not applicable.
: The authors declare that they have no competing interests.
